A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 200 shares of STRO stock, worth $827. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 7,800 97.44%
Holding current value
$827
Previous $44,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.92 - $5.33 $3.74 Million - $6.82 Million
1,279,166 Added 375.41%
1,619,907 $4.75 Million
Q1 2024

May 15, 2024

BUY
$3.27 - $5.65 $682,828 - $1.18 Million
208,816 Added 158.28%
340,741 $1.93 Million
Q4 2023

Feb 14, 2024

BUY
$2.07 - $4.54 $172,505 - $378,345
83,336 Added 171.51%
131,925 $565,000
Q3 2023

Nov 14, 2023

BUY
$3.29 - $4.9 $66,658 - $99,278
20,261 Added 71.52%
48,589 $168,000
Q2 2023

Aug 14, 2023

SELL
$4.25 - $5.88 $1.28 Million - $1.77 Million
-300,840 Reduced 91.39%
28,328 $131,000
Q1 2023

May 15, 2023

BUY
$4.48 - $8.45 $937,063 - $1.77 Million
209,166 Added 174.3%
329,168 $1.52 Million
Q4 2022

Feb 14, 2023

SELL
$5.41 - $8.08 $985,106 - $1.47 Million
-182,090 Reduced 60.28%
120,002 $969,000
Q3 2022

Nov 14, 2022

SELL
$5.17 - $7.11 $1.62 Million - $2.23 Million
-313,607 Reduced 50.94%
302,092 $1.68 Million
Q2 2022

Aug 15, 2022

BUY
$3.41 - $8.95 $879,282 - $2.31 Million
257,854 Added 72.06%
615,699 $3.21 Million
Q1 2022

May 16, 2022

SELL
$7.78 - $15.31 $1.86 Million - $3.66 Million
-238,925 Reduced 40.04%
357,845 $2.94 Million
Q4 2021

Feb 14, 2022

SELL
$14.25 - $23.53 $1.04 Million - $1.71 Million
-72,873 Reduced 10.88%
596,770 $8.88 Million
Q3 2021

Nov 15, 2021

SELL
$16.88 - $22.38 $1.53 Million - $2.02 Million
-90,351 Reduced 11.89%
669,643 $12.7 Million
Q2 2021

Aug 16, 2021

SELL
$18.03 - $23.82 $3.91 Million - $5.16 Million
-216,626 Reduced 22.18%
759,994 $14.1 Million
Q1 2021

May 17, 2021

SELL
$20.29 - $27.54 $6.42 Million - $8.71 Million
-316,384 Reduced 24.47%
976,620 $22.2 Million
Q4 2020

Feb 16, 2021

BUY
$10.16 - $23.98 $740,450 - $1.75 Million
72,879 Added 5.97%
1,293,004 $28.1 Million
Q3 2020

Nov 16, 2020

SELL
$7.44 - $13.15 $382,401 - $675,883
-51,398 Reduced 4.04%
1,220,125 $12.3 Million
Q2 2020

Aug 14, 2020

SELL
$7.24 - $11.05 $2.01 Million - $3.07 Million
-277,831 Reduced 17.93%
1,271,523 $9.87 Million
Q1 2020

May 15, 2020

SELL
$6.19 - $12.16 $1.11 Million - $2.18 Million
-179,622 Reduced 10.39%
1,549,354 $15.8 Million
Q4 2019

Feb 14, 2020

SELL
$8.15 - $11.39 $6,748 - $9,430
-828 Reduced 0.05%
1,728,976 $19 Million
Q3 2019

Nov 14, 2019

BUY
$7.91 - $11.76 $11,540 - $17,157
1,459 Added 0.08%
1,729,804 $15.7 Million
Q2 2019

Aug 14, 2019

SELL
$9.69 - $12.23 $8,314 - $10,493
-858 Reduced 0.05%
1,728,345 $19.7 Million
Q1 2019

May 15, 2019

BUY
$8.8 - $11.87 $1,408 - $1,899
160 Added 0.01%
1,729,203 $0
Q4 2018

Feb 14, 2019

SELL
$8.69 - $14.85 $168,394 - $287,763
-19,378 Reduced 1.11%
1,729,043 $15.6 Million
Q3 2018

Nov 13, 2018

BUY
$15.0 - $15.2 $26.2 Million - $26.6 Million
1,748,421 New
1,748,421 $0

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $216M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.